Dr. Leen Kawas Among Notable Speakers Sharing Insights During Abu Dhabi Finance Week
LOS ANGELES, CA / ACCESSWIRE / October 19, 2023 / As the world moves toward a global economy, numerous challenges and opportunities continue to impact the economic landscape. From November 27–30, 2023, thousands of prominent financial industry leaders will address these issues at the Abu Dhabi Finance Week (ADFW).
Held in the capital of the United Arab Emirates, this second-year event will explore the effects of emerging technological, economic, and sustainability phenomena on the financial arena. These recognized financial industry leaders include Leen Kawas, Ph.D. ( Propel Bio Partners’ Managing General Partner), Andre Esteves (Chairman of BTG Pactual) and Seik Fikry (CEO of Chimera).
Abu Dhabi Finance Week 2023 has been lauded as the pivotal finance, economic, and investment conference in the increasingly significant Middle East/North Africa (MENA) region. Under the respected auspices of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi, and the Executive Council Chairman, this large-scale gathering follows an extremely successful 2022 debut event. The inaugural conference drew more than 8,000 financial industry professionals from over 100 countries.
Investing in the Transition Era
The ADFW 2023 conference carries a bold “Investing in the Transition Era” theme. More than 30 distinctive events will take place during this landmark week. Three large-scale conventions will attract financial industry leaders with well-defined goals.
Investments and Fintechs
On November 27–28, Asset Abu Dhabi will feature a diverse cohort of global private market leaders. The world’s largest investment funds will send representatives to this key regional event. These financial industry professionals will explore value-based deals involving emerging investment vehicles and changing asset classes.
On November 29, Fintech Abu Dhabi marks the return of the MENA region’s largest financial festival. Technology innovators will share the spotlight with software developers, venture capitalists, and entrepreneurs. Collectively, these leaders will define new opportunities where finance and innovation intersect.
R.A.C.E. Abu Dhabi’s Multifaceted Focus
On November 30, R.A.C.E. Abu Dhabi will focus on multiple aspects of sustainable finance. Forward-focused financial institutions will be invited to help close the capital investment gap needed for the achievement of net zero. All involved will stay focused on the laudable goals of the net zero philosophy.
Concurrently, the R.A.C.E. breakout conversation will focus on Regulation, Awareness, Collaboration, and Ecosystem. While awareness and collaboration are certainly key, policymakers and regulators will help to shape the financial markets’ economic and regulatory ecosystem. Together, these key components will form the foundation of sustainable development.
Dr. Kawas will be part of a panel discussing recent innovation in the healthcare industry and opportunities presented for investors. Financial trends, regulatory environment, global collaborations that may impact the industry’s outlook.
The Capital Square Hub’s Opportunities
Like the MENA region’s vibrant markets, the Capital Square hub will host lively networking opportunities, investor meeting venues, and social events during ADFW’s duration. Collectively, these beneficial engagements will position the global financial industry for optimal growth along with an enhanced sustainability focus.
The Capital Square’s Startup Campus is of equal importance. In this mutually beneficial business environment, emerging entrepreneurs will interact with key startup arena leaders. Financial institutions and venture capital representatives will discuss funding options and scale-up strategies. Emerging entrepreneurs may set their sights on achieving the much-coveted “unicorn” status.
Highlighting Biotech at Abu Dhabi Finance Week
Dr. Leen Kawas Propel Bio Partners’ Managing General Partner. This Los Angeles-based firm seeks emerging biotechnology entrepreneurs who desire to augment their vision with financial capital and technical assistance from recognized experts.
Dr. Kawas relishes the opportunity to share her biotech knowledge with Propel Bio Partners’ clients. She is particularly open to discussions with women and minority biotech entrepreneurs.
Prior to her Propel Bio Partners’ role, Dr. Leen Kawas served as Athira Pharma, Inc.’s Chief Executive Officer. During her tenure at this Seattle-based firm, she drove the development of several promising drug candidates. Dr. Kawas also managed Athira Pharma’s Initial Public Offering in 2020. Her unwavering commitment to excellence, and her inspirational leadership, garnered her multiple industry awards.
Company: Propel Bio Partners
Person: Propel Bio Partners Info